Saturday 31 October 2026
Export GILD’s income statement to Excel — free account
Gilead Sciences, Inc.
GILD Healthcare Drug Manufacturers General
Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.
170.84
5.23
+3.16%
Follow GILD
Alert me
Gilead Sciences, Inc. (GILD) revenue by segment, product and region
Where the money comes from and where it goes
| U.S. | 20,876 | 70.90% |
|---|---|---|
| Europe | 5,064 | 17.20% |
| Rest of World | 3,503 | 11.90% |
| Gross margin | 78.83% | |
| Operating margin | 34.04% | |
| Pre-tax margin | 33.27% |
Revenue by region $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | 20,876 70.90% | 20,591 71.61% | 19,438 71.68% | 18,884 69.22% | 19,267 70.56% | 18,217 73.79% | 16,645 74.15% | 16,269 73.53% | 18,194 69.69% | 19,354 63.69% | 21,234 65.06% | 18,182 73.05% | 6,695 59.77% | 5,592 57.64% | 4,608 54.96% | 4,224 53.14% |
| Europe | 5,064 17.20% | 4,634 16.12% | 4,310 15.89% | 4,469 16.38% | 4,874 17.85% | 4,135 16.75% | 3,811 16.98% | 4,006 18.10% | 5,311 20.34% | 6,365 20.94% | 7,528 23.06% | 5,442 21.86% | 3,614 32.26% | 3,333 34.35% | 3,125 37.26% | 3,171 39.89% |
| Rest of World | 3,503 11.90% | 3,529 12.27% | 3,368 12.42% | 3,928 14.40% | 3,164 11.59% | 2,337 9.47% | 1,993 8.88% | 1,852 8.37% | 2,602 9.97% | 4,671 15.37% | 3,877 11.88% | 1,213 4.87% | 893 7.97% | 777 8.01% | 652 7.78% | 555 6.98% |
| Japan | — | — | — | — | — | — | — | — | — | — | — | 53 0.21% | — | — | — | — |
| Revenue | 29,443 | 28,754 | 27,116 | 27,281 | 27,305 | 24,689 | 22,449 | 22,127 | 26,107 | 30,390 | 32,639 | 24,890 | 11,202 | 9,702 | 8,385 | 7,949 |